Yongyun Li

No. 639, Zhizaoju Road
Huangpu, 200001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

A Signature of Typical MRI Features and Time-Intensity Curve Achieves Accurate Diagnosis of Distensible Orbital Venous Malformation.

A Signature of Typical MRI Features and Time-Intensity Curve Achieves Accurate Diagnosis of Distensible Orbital Venous Malformation.

Journal: Investigative ophthalmology & visual science

Published: December 12, 2025

Integrating spatial and single-cell transcriptomics analysis reveals MYCN-UBE2C-TFRC signaling endows ferroptosis resistance in neuroectodermal tumors.

Integrating spatial and single-cell transcriptomics analysis reveals MYCN-UBE2C-TFRC signaling endows ferroptosis resistance in neuroectodermal tumors.

Journal: Science China. Life sciences

Published: November 03, 2025

Aurora A Kinase Inhibition Is Synthetic Lethal With the Activation of MYCN in Retinoblastoma.

Aurora A Kinase Inhibition Is Synthetic Lethal With the Activation of MYCN in Retinoblastoma.

Journal: Investigative ophthalmology & visual science

Published: February 07, 2025

Single-cell sequencing depicts tumor architecture and empowers clinical decision in metastatic conjunctival melanoma.

Single-cell sequencing depicts tumor architecture and empowers clinical decision in metastatic conjunctival melanoma.

Journal: Cell discovery

Published: October 20, 2023

EHMT2 promotes tumorigenesis in GNAQ/11-mutant uveal melanoma via ARHGAP29-mediated RhoA pathway.

EHMT2 promotes tumorigenesis in GNAQ/11-mutant uveal melanoma via ARHGAP29-mediated RhoA pathway.

Journal: Acta pharmaceutica Sinica. B

Published: September 06, 2023

ARID1A loss promotes RNA editing of CDK13 in an ADAR1-dependent manner.

ARID1A loss promotes RNA editing of CDK13 in an ADAR1-dependent manner.

Journal: BMC biology

Published: July 11, 2023

High-risk histopathologic features in local advanced conjunctival melanoma.

High-risk histopathologic features in local advanced conjunctival melanoma.

Journal: Acta ophthalmologica

Published: June 24, 2023

Drug repurposing of propafenone to discover novel anti-tumor agents by impairing homologous recombination to delay DNA damage recovery of rare disease conjunctival melanoma.

Drug repurposing of propafenone to discover novel anti-tumor agents by impairing homologous recombination to delay DNA damage recovery of rare disease conjunctival melanoma.

Journal: European journal of medicinal chemistry

Published: November 20, 2022

Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway.

Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway.

Journal: Acta pharmaceutica Sinica. B

Published: January 07, 2022

Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle.

Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle.

Journal: Investigative ophthalmology & visual science

Published: December 13, 2021

Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.

Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.

Journal: Oncogene

Published: October 18, 2021

In Search of Excellence: From a Small Clinical Unit to an Internationally Recognized Center for Orbital Diseases Research and Surgery at the Department of Ophthalmology, Shanghai Ninth People's Hospital, China.

In Search of Excellence: From a Small Clinical Unit to an Internationally Recognized Center for Orbital Diseases Research and Surgery at the Department of Ophthalmology, Shanghai Ninth People's Hospital, China.

Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Published: September 15, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026